Estabrook Capital Management’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Estabrook Capital Management’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-400	Closed	-$10.9K	–	468
2015 Q1	$10.9K	Hold	400	–	–	﹤0.01%	364
2014 Q4	$10.6K	Hold	400	–	–	﹤0.01%	375
2014 Q3	$12.1K	Hold	400	–	–	﹤0.01%	365
2014 Q2	$12.6K	Hold	400	–	–	﹤0.01%	371
2014 Q1	$12.9K	Hold	400	–	–	﹤0.01%	370
2013 Q4	$14.5K	Hold	400	–	–	﹤0.01%	362
2013 Q3	$15.6K	Hold	400	–	–	﹤0.01%	360
2013 Q2	$15K	Buy	+400	New	+$15.8K	﹤0.01%	370

Other funds holding MR

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CCMH

Cornerstone Capital Management Holdings New York $14.3B AUM 33.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Estabrook Capital Management's MR Position: Q2 2015 in Review

Estabrook Capital Management sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 400 shares — an estimated $10.9K sold.

Estabrook Capital Management first reported a position in MR in Q2 2013 and held it in 8 quarters. The position peaked at $15.6K in Q3 2013. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

Estabrook Capital Management reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
Estabrook Capital Management sold 400 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $10.9K.
Estabrook Capital Management first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 8 quarters.
Estabrook Capital Management's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $15.6K in Q3 2013.
118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on Estabrook Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.